Celebrated for more than 25 years of innovation, entrepreneurship, and leadership in the pharmaceutical, wellness, and health technology sectors, Tracy “Trang” D. Nguyen has served as the chief executive officer and president of AQ Pharmaceuticals Inc. since 2000. Throughout her career, she has consistently looked beyond conventional healthcare models, seeking ways to combine science, technology, and human connection to improve everyday health and quality of life.
Under Ms. Nguyen’s leadership, AQ Pharmaceuticals has evolved from a traditional pharmaceutical and wellness company into a health technology innovator exploring the convergence of medical devices, wearable technologies, artificial intelligence, and preventive health. Her vision is rooted in a simple but powerful belief: the future of healthcare will not be defined by artificial intelligence alone, but by the intersection of AI and human touch.
Ms. Nguyen believes wearable technology should evolve beyond consumer gadgets and fitness accessories into intelligent, medical-grade health companions capable of helping individuals better understand their own physiology. Through the development of JBA AI and its BioBaseline™ platform, she is working toward a future in which wearable devices and AI-driven coaching can provide more personalized, continuous, and accessible health guidance for people around the world.
Ms. Nguyen has overseen the launch of several groundbreaking initiatives at AQ Pharmaceuticals. Among the most notable, she led the development and commercialization of low-level laser therapy technologies designed to provide drug-free wellness and pain management solutions. The company has also collaborated with Japanese partners on advanced health technologies, including innovative devices developed to support hair wellness and healthy aging.
Inspired by both modern science and traditional health practices from around the world, Ms. Nguyen has championed research initiatives focused on natural products and preventive health. Under her leadership, AQ Pharmaceuticals has developed products targeting blood sugar management, cardiovascular wellness, healthy aging, and overall metabolic health. Her work reflects a long-standing commitment to integrating scientific rigor with evidence-informed wellness solutions.
Innovation remains central to Ms. Nguyen’s leadership. As of 2026, she holds multiple provisional patents spanning artificial intelligence, neuroscience, health technology, wearable systems, and wellness innovations. Her intellectual property portfolio reflects her belief that technology should empower individuals to better understand and manage their health before disease develops.
One of Ms. Nguyen’s most ambitious initiatives is JBA AI (Joy, Beauty and Agelessness), a health intelligence platform that combines artificial intelligence, physiological modeling, smartphone-based assessments, and wearable technologies. Through innovations such as BioBaseline™, the platform seeks to move beyond isolated biometric readings and toward a more personalized understanding of each individual’s unique physiological patterns.
Ms. Nguyen envisions a future in which wearable devices are no longer viewed simply as accessories worn on the wrist or finger. Instead, she believes they will become intelligent health companions—medical-grade technologies capable of continuously learning from the human body and providing personalized insights that help individuals make better decisions about their health, lifestyle, and longevity.
Before venturing onto her vocational path, Ms. Nguyen established a strong academic foundation. She earned a Bachelor of Electrical Engineering from the University of Minnesota in 1985. The analytical thinking and scientific discipline developed through her engineering education would later become instrumental in her success as an entrepreneur, innovator, and business leader. She credits much of her professional growth to mentors who recognized her potential early in her career and encouraged her pursuit of leadership opportunities.
Throughout her career, Ms. Nguyen has received numerous honors recognizing both her entrepreneurial accomplishments and contributions to business diversity. AQ Pharmaceuticals has been recognized among leading Asian American and woman-owned businesses in the United States by organizations including Omnikal and DiversityBusiness.com. She has also been featured by prominent business publications for her leadership, innovation, and commitment to community impact.
Born in Saigon, Vietnam, Ms. Nguyen arrived in the United States as a refugee and built her career through determination, education, and a lifelong passion for science. Nearly five decades later, she remains driven by the same curiosity and sense of purpose that shaped her early journey.
Today, Ms. Nguyen’s focus extends beyond developing products. She is helping shape a vision for the next generation of healthcare—one in which wearable medical technologies, physiological intelligence, and artificial intelligence work together to support preventive wellness and healthier aging.
Ms. Nguyen believes the most meaningful future for AI is not replacing human relationships, but strengthening them. Through AQ Pharmaceuticals and JBA AI, she continues to advocate for a model where advanced technology is guided by empathy, trust, and human connection—where AI meets human touch.
As healthcare becomes increasingly digital, Ms. Nguyen’s long-term goal is to make personalized health intelligence more accessible, helping individuals understand their bodies earlier, make better decisions, and take a more active role in their own well-being. Her career stands as a reflection of resilience, innovation, and an enduring commitment to improving lives through science, technology, and compassionate leadership.